Details for Patent: 10,059,714
✉ Email this page to a colleague
Which drugs does patent 10,059,714 protect, and when does it expire?
Patent 10,059,714 protects TRUQAP and is included in one NDA.
This patent has forty-seven patent family members in thirty-eight countries.
Summary for Patent: 10,059,714
| Title: | Protein kinase B inhibitors |
| Abstract: | The invention relates to a novel group of compounds of Formula (I) or salts thereof: |
| Inventor(s): | Johnson Paul David, Leach Andrew, Luke Richard William Arthur, Matusiak Zbigniew Stanley, Morris Jeffrey James |
| Assignee: | AstraZeneca AB |
| Application Number: | US15351481 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 10,059,714
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | TRUQAP | capivasertib | TABLET;ORAL | 218197-001 | Nov 16, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Astrazeneca | TRUQAP | capivasertib | TABLET;ORAL | 218197-002 | Nov 16, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,059,714
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 068846 | ⤷ Sign Up | |||
| Argentina | 110013 | ⤷ Sign Up | |||
| Australia | 2008309383 | ⤷ Sign Up | |||
| Brazil | PI0818533 | ⤷ Sign Up | |||
| Canada | 2701057 | ⤷ Sign Up | |||
| Chile | 2008003023 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
